Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

ARCA biopharma, Inc. (NASDAQ:ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases announced that Dan Mitchell has been appointed to the Company’s Board of Directors. Arca Biopharma Inc. (NASDAQ:ABIO) stock performance was -2.31% in last session and finished the day at $2.11. Traded volume was 3.15 million shares in the last session and the average volume of the stock remained 862,287.00 shares. The beta … Continue reading Biotech Most Volatile: Arca Biopharma (NASDAQ:ABIO), Galena Biopharma (NASDAQ:GALE), Progenics Pharmaceuticals (NASDAQ:PGNX), AVEO Pharmaceuticals (NASDAQ:AVEO)

Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

CytRx Corporation (NASDAQ:CYTR) reported financial results for the 12 months ended December 31, 2013, and also provided an overview of recent accomplishments and upcoming milestones for its clinical development programs. CytRx Corporation (NASDAQ:CYTR) stock performance was -12.76% in last session and finished the day at $4.17. Traded volume was 11,065,087 million shares in the last session and the average volume of the stock remained 3.51 … Continue reading Biotech Losers: CytRx Corporation (NASDAQ:CYTR), Galena Biopharma (NASDAQ:GALE), Arena Pharmaceuticals (NASDAQ:ARNA), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Officials with Zogenix Inc. (NASDAQ:ZGNX), the San Diego-based maker of Zohydro, did not return a message seeking comment about the drug. The company is marketing the drug as the first extended-release hydrocodone pain reliever without acetaminophen, which can cause liver failure if taken in excess. Zogenix, Inc. (NASDAQ:ZGNX) stock performance was -14.18% in last session and finished the day at $3.84. Traded volume was 9.38million … Continue reading Healthcare Active runners: Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Galena Biopharma (NASDAQ:GALE), Gilead Sciences (NASDAQ:GILD)

Zacks Investment Research upgraded information technology services provider Xerox Corporation (NYSE:XRX) to a Zacks Rank #3 (Hold) from a Zacks Rank #4 (Sell) largely on the back of healthy long-term fundamentals fuelled by sustained product innovations. Xerox Corporation (NYSE:XRX) belongs to Technology sector. Its net profit margin is 5.30% and weekly performance is 0.16%. On last trading day company shares ended up $12.78. Xerox Corporation … Continue reading Trader’s Watch List : Xerox Corporation (NYSE:XRX), Sequenom Inc. (NASDAQ:SQNM), Galena Biopharma, Inc. (NASDAQ:GALE), Cathay General Bancorp (NASDAQ:CATY), Echelon Corporation (NASDAQ:ELON)

Lattice Semiconductor Corporation (NASDAQ:LSCC) today announced that it is scheduled to present at Jefferies Semiconductors, Hardware & Communications Infrastructure Summit taking place on Wednesday, August 27th at the Ritz Carlton in Chicago. Lattice Semiconductor Corporation (NASDAQ:LSCC) belongs to Technology sector. Its net profit margin is 10.50% and weekly performance is 4.81%. On last trading day company shares ended up $7.53. Lattice Semiconductor Corporation (NASDAQ:LSCC) distance … Continue reading Momentum Stocks: Lattice Semiconductor (NASDAQ:LSCC), CVS Caremark (NYSE:CVS), Silicom (NASDAQ:SILC), Galena Biopharma, Inc. (NASDAQ:GALE), Alexander & Baldwin, Inc. (NYSE:ALEX)

Gilead Sciences’ controversial $1,000-a-day Sovaldi pill is priced in line with previous treatments for Hepatitis C, but the nation’s health-care system likely won’t be able to handle that kind of sticker shock, and competition probably will bring down that price tag in coming months and years. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was 4.84% in last session and finished the day at $89.19. Traded volume … Continue reading Investors Alert – Gilead Sciences (NASDAQ:GILD) , Galena Biopharma (NASDAQ:GALE) , RPI , UnitedHealth (NYSE:UNH) , China Automotive (NASDAQ:CAAS)